ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

House Members Express Support for Cancer Program

September 12, 1980

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

FDA Clears Rapid Test For Aspergillus Infection

May 30, 2003

Rauscher Disappointed In CREG Progress

October 1, 1976